Anti-cMet & EGFR Reference Antibody (Amivantamab)
Produktgrößen
100 ug
£495,00
CHBA048-100UG
1 mg
£1135,00
CHBA048-1MG
Über dieses Produkt
- SKU:
- CHBA048
- Zusätzliche Namen:
- Amivantamab
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Lulizumab is a monovalent Anti-Human CD28 Domain Antibody Antagonist designed for the treatment of autoimmune diseases.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- HGFR / c-Met,ERBB1 / EGFR / HER1
- Molekulargewicht:
- 145.9 kDa
- Reinheit:
- >95%
- Aufreinigung:
- Protein A Purified
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -70[o]C Aliquot. Avoid freeze/thaw cycles., -20[o]C Aliquot. Avoid freeze/thaw cycles., 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Recombinant Antibodies
- Datenblatt des Herstellers:CHBA048